Dynamic Modeling of Complex Biological Signals Using Neural ODEs

Published: September 9, 2025

Overview

Pharmaceutical research teams are often faced with an uphill task: drawing meaning from sparse, noisy, and irregularly sampled clinical data. Traditional modeling methods — particularly static and linear approaches — struggle to capture the time-dependent nature of biological processes, leaving researchers with limited predictive accuracy and little decision support.

Reveal partnered with a leading pharmaceutical research client to turn this challenge into an opportunity. By applying Neural Ordinary Differential Equations (Neural ODEs), we built a framework that could not only model dynamic biomarkers with precision but also forecast patient trajectories and uncover hidden signals that shape downstream clinical research and strategy.

‍Key Challenges

• Irregular and incomplete datasets made it difficult to discover meaningful biological patterns.
• Static and linear models could not capture the dynamics of time-dependent processes.
• Limited insight into strategy and decision-making left teams without clear guidance for clinical development.

Our Approach

Reveal designed and implemented a Neural ODE-based architecture, trained on both real-world and synthetic datasets. This allowed the client to:

• Learn non-linear, time-dependent patterns directly from the data, without restrictive assumptions.
• Seamlessly integrate categorical, continuous, and time-series data into one modeling pipeline.
• Reduce noise and overfitting through feature selection, regularization, and latent space optimization.
• Generate interpretable latent vectors, enabling downstream tasks like cohort identification, treatment arm selection, and response prediction.

Project Success

This collaboration delivered results that went beyond technical accuracy:

• Dynamic biomarkers were modeled with precision, even from complex datasets.
• The client gained predictive insights into patient trajectories and treatment effects.
• A modular, explainable, and adaptable framework was established, making the solution transferable across therapeutic areas.

Impact

The shift from static to dynamic modeling proved transformative:

• Up to 3x improvement over linear benchmarks.
• Strong performance in cohort identification and classification.
• Robust handling of irregular dosing times and missing data.
• Greater generalizability through feature reduction without sacrificing accuracy.

Most importantly, the client now had a scalable, disease-agnostic solution capable of:

• Turning messy, longitudinal data into actionable intelligence.
• Accelerating biomarker discovery, cohort design, and clinical strategy.
• Moving beyond static endpoints to unlock the full potential of real-world, time-dependent clinical data.

‍